Mini-review: Antibody-PET of receptor tyrosine kinase interplay and heterogeneity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mini-review: Antibody-PET of receptor tyrosine kinase interplay and heterogeneity
Authors
Keywords
RTK, Heterogeneity, Co-activation, Antibody, PET/CT
Journal
NUCLEAR MEDICINE AND BIOLOGY
Volume 108-109, Issue -, Pages 70-75
Publisher
Elsevier BV
Online
2022-03-18
DOI
10.1016/j.nucmedbio.2022.03.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo
- (2021) Giorgia Foggetti et al. Cancer Discovery
- Copper-67 radioimmunotheranostics for simultaneous immunotherapy and immuno-SPECT
- (2021) Guiyang Hao et al. Scientific Reports
- PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology
- (2021) Sara S. Rinne et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- [89Zr]-Pertuzumab PET Imaging Reveals Paclitaxel Treatment Efficacy Is Positively Correlated with HER2 Expression in Human Breast Cancer Xenograft Mouse Models
- (2021) Yun Lu et al. MOLECULES
- FDA approves 100th monoclonal antibody product
- (2021) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Impact of HER2 heterogeneity on treatment response of early-stage HER2-positive breast cancer: phase II neoadjuvant clinical trial of T-DM1 combined with pertuzumab
- (2021) Otto Metzger Filho et al. Cancer Discovery
- Molecular Imaging of Angiogenesis in Oncology: Current Preclinical and Clinical Status
- (2021) Alexandru Florea et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ERK Inhibition Improves Anti–PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma
- (2021) Kelly E. Henry et al. MOLECULAR CANCER THERAPEUTICS
- Spatial omics and multiplexed imaging to explore cancer biology
- (2021) Sabrina M. Lewis et al. NATURE METHODS
- When the MET receptor kicks in to resist targeted therapies
- (2021) Marie Fernandes et al. ONCOGENE
- A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer
- (2021) Chul Kim et al. Frontiers in Oncology
- First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography
- (2020) Simone Krebs et al. JOURNAL OF NUCLEAR MEDICINE
- Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors
- (2020) Junji Tsurutani et al. Cancer Discovery
- Impact of 68Ga-NOTA-MAL-MZHER2 PET imaging in advanced gastric cancer patients and therapeutic response monitoring
- (2020) Nina Zhou et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Development of [89Zr]ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer
- (2020) Alessandra Cavaliere et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- ImmunoPET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition
- (2020) Patricia M. R. Pereira et al. JOURNAL OF NUCLEAR MEDICINE
- Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CT
- (2020) Gary A. Ulaner et al. RADIOLOGY
- Acute statin treatment improves antibody accumulation in EGFR- and PSMA-expressing tumors
- (2020) Patricia M.R. Pereira et al. CLINICAL CANCER RESEARCH
- First Human Imaging Studies with the EXPLORER Total-Body PET Scanner*
- (2019) Ramsey D. Badawi et al. JOURNAL OF NUCLEAR MEDICINE
- Positron Emission Tomography Imaging of Platelet-Derived Growth Factor Receptor β in Colorectal Tumor Xenograft Using Zirconium-89 Labeled Dimeric Affibody Molecule
- (2019) Huawei Cai et al. MOLECULAR PHARMACEUTICS
- Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors
- (2019) Patricia MR Pereira et al. JOURNAL OF NUCLEAR MEDICINE
- HER2-Targeted PET Imaging and Therapy of Hyaluronan-Masked HER2-Overexpressing Breast Cancer
- (2019) Patricia M. R. Pereira et al. MOLECULAR PHARMACEUTICS
- Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer
- (2018) Farrokh Dehdashti et al. BREAST CANCER RESEARCH AND TREATMENT
- Imaging of human epidermal growth factor receptors for patient selection and response monitoring – From PET imaging and beyond
- (2018) Patricia M.R. Pereira et al. CANCER LETTERS
- HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-Based PET Imaging
- (2018) Carlos D. Martins et al. CLINICAL CANCER RESEARCH
- Development of64Cu-NOTA-Trastuzumab for HER2 targeting: radiopharmaceutical with improved pharmacokinetics for human study
- (2018) Sang-Keun Woo et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRα) in papillary thyroid cancer using immuno-PET
- (2018) Michael Wagner et al. NUCLEAR MEDICINE AND BIOLOGY
- Imaging EGFR and HER3 through 89Zr-labeled MEHD7945A (Duligotuzumab)
- (2018) Brooke N. McKnight et al. Scientific Reports
- 89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
- (2018) Frederike Bensch et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET Imaging of Receptor Tyrosine Kinases in Cancer
- (2018) Weijun Wei et al. MOLECULAR CANCER THERAPEUTICS
- Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy
- (2018) Patrícia M. R. Pereira et al. Nature Communications
- EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
- (2018) Francisco Sanchez-Vega et al. Cancer Discovery
- Pharmacokinetics, Biodistribution, and Radiation Dosimetry for89Zr-Trastuzumab in Patients with Esophagogastric Cancer
- (2017) Joseph A. O'Donoghue et al. JOURNAL OF NUCLEAR MEDICINE
- Tumor Uptake of64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer
- (2017) Joanne E. Mortimer et al. JOURNAL OF NUCLEAR MEDICINE
- Human Epidermal Growth Factor Receptor 3–Specific Tumor Uptake and Biodistribution of 89 Zr-MSB0010853 Visualized by Real-Time and Noninvasive PET Imaging
- (2017) Frank J. Warnders et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular Imaging of IGF-1R in Cancer
- (2017) Yingying Sun et al. Molecular Imaging
- Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
- (2016) Filippo Pietrantonio et al. CLINICAL CANCER RESEARCH
- Development of Lu-177-trastuzumab for radioimmunotherapy of HER2 expressing breast cancer and its feasibility assessment in breast cancer patients
- (2016) Priya Bhusari et al. INTERNATIONAL JOURNAL OF CANCER
- Lung Cancer in the Era of Precision Medicine
- (2015) K. Politi et al. CLINICAL CANCER RESEARCH
- Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies
- (2014) Chong Sun et al. TRENDS IN BIOCHEMICAL SCIENCES
- Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
- (2011) J. T. Garrett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Met Receptor Contributes to Trastuzumab Resistance of Her2-Overexpressing Breast Cancer Cells
- (2008) D. L. Shattuck et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started